Search Results - "Leren, T. P."

Refine Results
  1. 1

    The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis by Mousavi, S. A., Berge, K. E., Leren, T. P.

    Published in Journal of internal medicine (01-12-2009)
    “… The LDL receptor (LDLR) plays an essential role in the regulation of plasma (LDL) cholesterol concentrations by virtue of its ability to clear plasma LDL…”
    Get full text
    Journal Article
  2. 2

    Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia by Leren, TP

    Published in Clinical genetics (01-05-2004)
    “…Proprotein convertase subtilisin/kexin type 9 (PCSK9) is at a locus for autosomal dominant hypercholesterolemia, and recent data indicate that the PCSK9 gene…”
    Get full text
    Journal Article
  3. 3

    Cascade genetic screening for familial hypercholesterolemia by Leren, TP

    Published in Clinical genetics (01-12-2004)
    “…Familial hypercholesterolemia (FH) is caused by a mutation in the low‐density lipoprotein receptor gene and is characterized by hypercholesterolemia,…”
    Get full text
    Journal Article
  4. 4

    Characterization of novel mutations in the catalytic domain of the PCSK9 gene by Cameron, J., Holla, Ø. L., Laerdahl, J. K., Kulseth, M. A., Ranheim, T., Rognes, T., Berge, K. E., Leren, T. P.

    Published in Journal of internal medicine (01-04-2008)
    “… Objectives.  To expand our understanding of the structure and function of proprotein convertase subtilisin/kexin type 9 (PCSK9) by studying how naturally…”
    Get full text
    Journal Article
  5. 5

    Genetics of hypertrophic cardiomyopathy in Norway by Berge, K.E., Leren, T.P.

    Published in Clinical genetics (01-10-2014)
    “…Genetic testing for hypertrophic cardiomyopathy (HCM) became available in Norway in 2003. Here, we describe the results of this testing in probands with HCM…”
    Get full text
    Journal Article
  6. 6

    Molecular autopsy in young sudden cardiac death victims with suspected cardiomyopathy by Larsen, M.K, Nissen, P.H, Berge, K.E, Leren, T.P, Kristensen, I.B, Jensen, H.K, Banner, J

    Published in Forensic science international (10-06-2012)
    “…Abstract The aim of this investigation was to identify and characterise pathogenic mutations in a sudden cardiac death (SCD) cohort suspected of cardiomyopathy…”
    Get full text
    Journal Article
  7. 7

    Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases by Larsen, M. K., Berge, K. E., Leren, T. P., Nissen, P. H., Hansen, J., Kristensen, I. B., Banner, J., Jensen, H. K.

    Published in International journal of legal medicine (01-01-2013)
    “…The aim of this investigation was to identify pathogenic variants of the ryanodine receptor 2 ( RYR2 ) gene in a cohort of persons aged 0–40 years who died of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Risk Factors Related to Carotid Intima-Media Thickness and Plaque in Children With Familial Hypercholesterolemia and Control Subjects by Tonstad, Serena, Joakimsen, Oddmund, Stensland-Bugge, Eva, Leren, Trond P, Ose, Leiv, Russell, David, Bonaa, Kaare H

    “…To assess the relationship between risk factors for cardiovascular disease and early atherosclerotic changes in the carotid artery, we measured carotid…”
    Get full text
    Journal Article
  10. 10

    Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia by Caddeo, A., Mancina, R.M., Pirazzi, C., Russo, C., Sasidharan, K., Sandstedt, J., Maurotti, S., Montalcini, T., Pujia, A., Leren, T.P., Romeo, S., Pingitore, P.

    “…Type I hyperlipoproteinemia, also known as familial chylomicronemia syndrome (FCS), is a rare autosomal recessive disorder caused by variants in LPL, APOC2,…”
    Get full text
    Journal Article
  11. 11

    Molecular genetics of familial hypercholesterolaemia in Norway by LEREN, T. P., TONSTAD, S., GUNDERSEN, K. E., BAKKEN, K. S., RØDNINGEN, O. K., SUNDVOLD, H., OSE, L., BERG, K.

    Published in Journal of internal medicine (01-03-1997)
    “…Objectives. To characterize mutations in the low density lipoprotein (LDL) receptor gene causing familial hypercholesterolaemia (FH) amongst Norwegian…”
    Get full text
    Journal Article
  12. 12

    A Functional Polymorphism in the Promoter Region of the Microsomal Triglyceride Transfer Protein (MTP −493G/T) Influences Lipoprotein Phenotype in Familial Hypercholesterolemia by Lundahl, Björn, Leren, Trond P, Ose, Leiv, Hamsten, Anders, Karpe, Fredrik

    “…The microsomal triglyceride transfer protein (MTP) has a key function in intracellular apolipoprotein (apo) B lipidation and secretion of very low density…”
    Get full text
    Journal Article
  13. 13

    Is responsiveness to lovastatin in familial hypercholesterolaemia heterozygotes influenced by the specific mutation in the low-density lipoprotein receptor gene? by Leren, T P, Hjermann, I

    Published in European journal of clinical investigation (01-12-1995)
    “…Lovastatin is one of the most commonly used lipid-lowering drugs in familial hypercholesterolaemia (FH) heterozygotes. In order to study whether the response…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects by Tonstad, S, Joakimsen, O, Stensland-Bugge, E, Ose, L, Bønaa, K H, Leren, T P

    Published in European journal of clinical investigation (01-12-1998)
    “…Background In individuals with familial hypercholesterolaemia (FH), ultrasonographic measurement of carotid intima–media thickness (IMT) and plaque may provide…”
    Get full text
    Journal Article
  16. 16

    Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia? by Tonstad, S, Joakimsen, O, Leren, TP, Ose, L

    Published in Acta Paediatrica (01-12-2000)
    “…Maternal hypercholesterolaemia has recently been shown to increase the number of fatty streaks in the foetal aorta, as well as subsequent progression of fatty…”
    Get full text
    Journal Article
  17. 17

    Screening for mutations of the apolipoprotein B gene causing hypocholesterolemia by LEREN, T. P, BAKKEN, K. S, HOEL, V, HJERMANN, I, BERG, K

    Published in Human genetics (01-01-1998)
    “…In this study we have performed analyses of apolipoprotein (apo) B at both the protein and gene level to search for mutations of the apoB gene causing…”
    Get full text
    Journal Article
  18. 18

    Screening for point mutations by semi-automated DNA sequencing using sequenase and magnetic beads by Leren, T P, Rødningen, O K, Røsby, O, Solberg, K, Berg, K

    Published in BioTechniques (01-04-1993)
    “…We have established an improved method for detecting point mutations by semi-automated DNA sequencing of PCR fragments generated from genomic DNA. The method…”
    Get more information
    Journal Article
  19. 19

    Application of long polymerase chain reaction in the study of the LDL receptor gene by Rødningen, O K, Leren, T P

    “…In this report we have applied an improved method of the polymerase chain reaction (PCR) in order to detect structural aberrations and point mutations in the…”
    Get more information
    Journal Article
  20. 20

    Characterization of a human apolipoprotein E gene enhancer element and its associated protein factors by CHANG, D. J, PAIK, Y.-K, LEREN, T. P, WALKER, D. W, HOWLETT, G. J, TAYLOR, J. M

    Published in The Journal of biological chemistry (05-06-1990)
    “…An enhancer element in the 5' flanking region of the human apolipoprotein E gene, known as upstream regulatory element 1 (URE1), has previously been implicated…”
    Get full text
    Journal Article